Tarena International, Inc. has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because TEDU is now in overbought territory with an RSI value of 76.50.
What is RSI?
RSI stands for ‘Relative Strength Index’ and it is a popular indicator used by technically focused investors. It compares the average of gains in days that closed up to the average of losses in days that closed down; readings above 70 suggest an asset is overbought, while an RSI below 30 suggests undervalued conditions are present.
Other Factors
Yet TEDU’s high RSI value isn’t the only reason for investors to be concerned, as there has been some decidedly negative earnings estimate revisions inTarena International’s stock as of late. This is especially true when investors dive into some of these revisions in order to get a better picture of TEDU’s prospects for the near term.
Over the past two months, investors have witnessed 1 earnings estimates revision lower compared to none higher for the current year. The consensus estimate for TEDU has also been on a downward trend over the same time period too, as the estimate has fallen from $0.88/share two months ago to just $0.86/share today.
If this wasn’t enough, Tarena International also has a Zacks Rank #4 (Sell)which puts it into unfortunate company among its peers. So, given all of these factors, investors may want to consider exiting this stock now before it falls back to Earth. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
Image: Bigstock
Tarena International (TEDU) is in Overbought Territory: What's Next?
Tarena International, Inc. has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because TEDU is now in overbought territory with an RSI value of 76.50.
What is RSI?
RSI stands for ‘Relative Strength Index’ and it is a popular indicator used by technically focused investors. It compares the average of gains in days that closed up to the average of losses in days that closed down; readings above 70 suggest an asset is overbought, while an RSI below 30 suggests undervalued conditions are present.
Other Factors
Yet TEDU’s high RSI value isn’t the only reason for investors to be concerned, as there has been some decidedly negative earnings estimate revisions inTarena International’s stock as of late. This is especially true when investors dive into some of these revisions in order to get a better picture of TEDU’s prospects for the near term.
Over the past two months, investors have witnessed 1 earnings estimates revision lower compared to none higher for the current year. The consensus estimate for TEDU has also been on a downward trend over the same time period too, as the estimate has fallen from $0.88/share two months ago to just $0.86/share today.
If this wasn’t enough, Tarena International also has a Zacks Rank #4 (Sell)which puts it into unfortunate company among its peers. So, given all of these factors, investors may want to consider exiting this stock now before it falls back to Earth. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>